Brief: Vicore Pharma Restarts Mechanistic Study With Vp01 In Systemic Sclerosis
25/08/2020 07:07
Aug 25 (Reuters) - Vicore Pharma Holding AB VICOR.ST :
* VICORE PHARMA RESTARTS MECHANISTIC STUDY WITH VP01 IN SYSTEMIC SCLEROSIS
* VICORE PHARMA HOLDING AB - PATIENTS ARE AGAIN BEING ENROLLED IN SYSTEMIC SCLEROSIS STUDY
AFTER
PAUSE DUE TO COVID-19 PANDEMIC.
Source text for Eikon: ID:nWkr2y4GNw
Further company coverage: VICOR.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Vicore Pharma Holding AB
See all newsBrief: Vicore Pharma Holding Q3 Net Revenues Amounted To Sek 0.6 Mln
Brief: Vicore Pharma Holding AB Phase 2B Aspire Trial Of Buloxibutid In Ipf Passes Pre-Planned Futility Analysis, On Track For Mid-2027 Topline Results
Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:53 PM
Brief: Vicore Pharma Shares Start Trading In US On July 2